TNFRSF13B
Tumor necrosis factor receptor superfamily member 13B
Also known as: CD267, IGAD2, TACI, TR13B_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O14836
- Gene
- TNFRSF13B
- Ensembl
- ENSG00000240505
- Chromosome
- 17
- Canonical length
- 293 aa
- Protein class
- CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins
OverviewNCBI Gene
The protein encoded by this gene is a lymphocyte-specific member of the tumor necrosis factor (TNF) receptor superfamily. It interacts with calcium-modulator and cyclophilin ligand (CAML). The protein induces activation of the transcription factors NFAT, AP1, and NF-kappa-B and plays a crucial role in humoral immunity by interacting with a TNF ligand. This gene is located within the Smith-Magenis syndrome region on chromosome 17. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
293 residues, UniProt reviewed canonical sequence.
>O14836|TNFRSF13B
1 MSGLGRSRRG GRSRVDQEER FPQGLWTGVA MRSCPEEQYW DPLLGTCMSC KTICNHQSQR
61 TCAAFCRSLS CRKEQGKFYD HLLRDCISCA SICGQHPKQC AYFCENKLRS PVNLPPELRR
121 QRSGEVENNS DNSGRYQGLE HRGSEASPAL PGLKLSADQV ALVYSTLGLC LCAVLCCFLV
181 AVACFLKKRG DPCSCQPRSR PRQSPAKSSQ DHAMEAGSPV STSPEPVETC SFCFPECRAP
241 TQESAVTPGT PDPTCAGRWG CHTRTTVLQP CPHIPDSGLG IVCVPAQEGG PGALocalizationUniProt · AlphaFold · HPA
Whether an antibody against TNFRSF13B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.62
- Highest tissue expression
- 59 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 59 nTPM
- spleen: 30 nTPM
- tonsil: 21 nTPM
- small intestine: 17 nTPM
- lymph node: 15 nTPM
- appendix: 8.1 nTPM
Single-cell type
- plasma cells: 177 nCPM
- b-cells: 133 nCPM
- platelets: 11 nCPM
- gastric chief cells: 6.6 nCPM
- pdcs: 6.5 nCPM
- foveolar cells: 4.3 nCPM
Immune cell
- memory B-cell: 131 nTPM
- naive B-cell: 52 nTPM
- total PBMC: 2.7 nTPM
- T-reg: 2.2 nTPM
- neutrophil: 0.5 nTPM
- basophil: 0.1 nTPM
Brain region
- white matter: 3 nTPM
- pons: 2.5 nTPM
- basal ganglia: 1.5 nTPM
- cerebral cortex: 1.5 nTPM
- medulla oblongata: 1.5 nTPM
- thalamus: 1.4 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about TNFRSF13B.
Disease | AllUniProt
Conditions TNFRSF13B is implicated in, by any mechanism.
- Immunodeficiency, common variable, 2 (CVID2) MIM:240500
- Immunoglobulin A deficiency 2 (IGAD2) MIM:609529
Disease | GeneticClinVar
34 pathogenic / likely-pathogenic of 380 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Immunodeficiency, common variable, 2
- Immunoglobulin A deficiency 2
- TNFRSF13B-related disorder
- Immunodeficiency, common variable, 1
- Common variable immunodeficiency
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.96
- gnomAD pLI
- 0
- gnomAD missense Z
- -1.2
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adaptive immune response
- B cell homeostasis
- cell surface receptor signaling pathway
- hematopoietic progenitor cell differentiation
- negative regulation of B cell proliferation
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- TACI, cysteine-rich domain
- Tumour necrosis factor receptor 13B
- TACI, cysteine-rich domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TNFRSF13B in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TNFRSF13B as an antibody target. Whether an autoantibody or antibody against TNFRSF13B could matter depends on whether native TNFRSF13B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TNFRSF13B is annotated at the cell surface, where native TNFRSF13B is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Source-annotated serology context
The source annotations explicitly mention antibody, autoantibody, autoantigen, or autoimmune context. This is biological context, not study-specific reactivity.
- The protein induces activation of the transcription factors NFAT, AP1, and NF-kappa-B and plays a crucial role in humoral immunity by interacting with a TNF ligand.
Loading the interactive Seroatlas protein explorer...